Hypopigmentation, where patches of skin become lighter than the surrounding area, is treatable in most cases. The right approach depends entirely on what caused the light patches in the first place. Some forms resolve on their own within months, while others require targeted therapy over weeks or years. Understanding which type you’re dealing with is the first step toward effective treatment.
Why Skin Loses Color
Skin color comes from melanin, a pigment produced by specialized cells called melanocytes. Hypopigmentation happens when the body produces less melanin than usual, or when the tiny packages that deliver melanin to skin cells (called melanosomes) decrease in number. This is different from depigmentation, where melanocytes are destroyed entirely, as in vitiligo, leaving skin chalky white rather than just lighter.
The most common causes of lighter skin patches include post-inflammatory hypopigmentation (after a burn, rash, or skin procedure), pityriasis alba (dry, pale patches common in children), tinea versicolor (a fungal infection that disrupts pigment), and vitiligo (an autoimmune condition). Each has a different treatment path.
Post-Inflammatory Hypopigmentation
If your light patches appeared after a skin injury, acne, eczema flare, laser treatment, or chemical peel, you’re dealing with post-inflammatory hypopigmentation. This is among the most common types, and the good news is that it often resolves without treatment. The timeline varies considerably. Mild cases can repigment within a few months, while others take a year or longer. Some forms, like the hypopigmentation that follows lichen striatus (a streaky rash), can persist for years after the original rash clears.
The most important thing you can do is address whatever caused the inflammation in the first place. If eczema triggered the light patches, getting the eczema under control prevents new patches from forming. Keeping the skin well moisturized supports the healing process. Sun protection is also key: unprotected UV exposure will tan the surrounding skin while the lighter patch stays pale, making the contrast more noticeable and potentially slowing recovery.
Treating Pityriasis Alba
Pityriasis alba shows up as round or oval pale patches, often on the face, and is especially common in children. It’s a self-limited condition, meaning most cases resolve within one year without aggressive treatment.
The foundation of treatment is simple moisturizing. A bland emollient cream applied daily, especially right after bathing, helps reduce the dry, scaly texture of the patches. For patches that are itchy or slightly red in their early stages, a low-potency steroid cream like hydrocortisone 1% can help calm inflammation and may speed up repigmentation. Only low-potency steroids should be used for this condition, particularly on the face, and with frequent breaks to avoid thinning the skin over time.
Tinea Versicolor
When a yeast called Malassezia overgrows on the skin, it alters normal melanin production and creates small, scattered patches of discoloration. Antifungal treatment, either topical or oral, kills the yeast. However, even after successful treatment, the light patches can take weeks to months to blend back in with surrounding skin. This lag is normal and doesn’t mean the treatment failed. The fungus is gone, but the melanocytes need time to resume full pigment production.
Topical Treatments for Vitiligo
Vitiligo requires more targeted treatment because the melanocytes themselves are destroyed by the immune system. Three main topical options can help restore color.
Corticosteroid Creams
Topical steroids are often the first treatment tried for vitiligo patches. They work by suppressing the immune attack on melanocytes. Medium-potency steroids can be used for up to 12 weeks, while super-high-potency formulations are limited to 3 weeks. On thin skin like the face, eyelids, or groin, shorter durations and lower-potency options are necessary to prevent skin thinning.
Calcineurin Inhibitors
Tacrolimus ointment is a non-steroidal option that calms the local immune response without the risk of skin thinning. It’s applied once or twice daily, with twice-daily application producing better results. The most common side effect is a temporary burning or tingling sensation, reported in up to 58% of users. Itching occurs in about 46%. These side effects typically fade as the skin adjusts, and the overall safety profile is favorable, making it a particularly good option for facial vitiligo or long-term use where steroids would be risky.
Ruxolitinib Cream
This is the first FDA-approved topical treatment specifically for vitiligo. It works by blocking signals that drive the immune attack on pigment cells. In pooled data from two large clinical trials, about 50% of patients who used the cream consistently for a year achieved 75% or greater repigmentation on their face. Patients who started treatment later, after an initial 24-week period, still saw results: roughly 28% reached that same level of repigmentation after 28 weeks of active use.
Light and Laser Therapy
Narrowband UVB phototherapy and the 308-nm excimer laser are the primary light-based treatments for hypopigmentation, particularly vitiligo. The excimer laser delivers concentrated UV light directly to affected patches, sparing surrounding skin.
Treatment frequency matters significantly in the early weeks. In a controlled study, patients treated three times per week showed repigmentation in 62% of lesions after just 6 weeks, compared to only 8% with once-weekly treatment. By 12 weeks, the gap narrowed: projected repigmentation rates reached 82% for three-times-weekly treatment versus 60% for once-weekly. The takeaway is that more frequent sessions produce faster results, but the total number of sessions matters more than how they’re spaced. Treatment periods beyond 12 weeks are often necessary, especially with less frequent scheduling.
Encouragingly, repigmentation from excimer laser therapy persisted in most patients over a 12-month follow-up period after treatment ended.
Surgical Options for Stable Vitiligo
When vitiligo has been stable for at least one year, with no new patches forming and no existing patches expanding, surgical approaches become an option. The most studied technique is non-cultured epidermal cell suspension grafting, where a small sample of your pigmented skin is processed into a cell suspension and applied to the depigmented area.
Success rates vary widely across studies, with more than 75% repigmentation reported in anywhere from 27% to 100% of patients depending on the study. The best candidates are those with confirmed disease stability and no history of raised scarring. People who develop new lesions at sites of skin injury (a phenomenon called Koebner response) are generally not good candidates, since the surgical procedure itself could trigger new depigmentation.
Combination Approaches
Treatments are frequently combined for better outcomes. Topical calcineurin inhibitors or corticosteroids are often paired with light therapy to boost repigmentation rates beyond what either achieves alone. Microneedling, which creates tiny punctures in the skin to stimulate a healing response, is being studied in combination with various topical agents to enhance penetration and melanocyte activation. These combination strategies are especially relevant for stubborn patches that haven’t responded to a single treatment.
Protecting Lighter Skin From Sun Damage
Hypopigmented skin has less melanin, which means less natural UV protection. A broad-spectrum sunscreen with SPF 50+ is recommended for pigmentary disorders, with balanced UVA and UVB protection. This protects the lighter patches from sunburn while also preventing the surrounding skin from tanning darker and increasing the visible contrast.
There’s one notable exception. Expert guidelines for vitiligo suggest that brief, controlled UV exposure to affected patches (without sunscreen) can actually stimulate repigmentation, but only until the patches start turning pink. Once any pinkness or repigmentation appears, switching to SPF 50+ sunscreen is important to prevent sunburn, which can trigger new patches through the Koebner response.
For people with medium to dark skin tones, tinted sunscreens containing iron oxide offer additional protection against visible light, which can worsen pigmentation irregularities in darker skin types.
What Realistic Recovery Looks Like
Repigmentation is a slow process regardless of the treatment used. Melanocytes need time to regenerate, migrate into depigmented areas, and resume melanin production. Most topical treatments require at least 3 to 6 months of consistent use before meaningful color return becomes visible. Light therapy typically needs 12 or more weeks, often longer. Post-inflammatory hypopigmentation can take anywhere from a few months to over a year to resolve naturally.
Skin on the face and neck tends to repigment fastest because these areas have a higher density of melanocyte reservoirs around hair follicles. Hands, feet, and bony prominences are the most resistant to treatment. Color often returns in a speckled pattern at first, with small dots of pigment appearing around hair follicles and gradually expanding to fill in the patch. Patience and consistent treatment are the most important factors in achieving the best possible outcome.